Enzolytics Stock Current Ratio
| ENZC Stock | USD 0.0009 0.0001 10.00% |
Enzolytics fundamentals help investors to digest information that contributes to Enzolytics' financial success or failures. It also enables traders to predict the movement of Enzolytics Pink Sheet. The fundamental analysis module provides a way to measure Enzolytics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Enzolytics pink sheet.
Enzolytics |
Enzolytics Company Current Ratio Analysis
Enzolytics' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Enzolytics Current Ratio | 0.01 X |
Most of Enzolytics' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enzolytics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Enzolytics has a Current Ratio of 0.01 times. This is 99.66% lower than that of the Healthcare sector and 99.86% lower than that of the Biotechnology industry. The current ratio for all United States stocks is 99.54% higher than that of the company.
Enzolytics Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enzolytics' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Enzolytics could also be used in its relative valuation, which is a method of valuing Enzolytics by comparing valuation metrics of similar companies.Enzolytics is currently under evaluation in current ratio category among its peers.
Enzolytics Fundamentals
| Return On Asset | -7.05 | |||
| Operating Margin | (19.24) % | |||
| Current Valuation | 71.57 M | |||
| Shares Outstanding | 2.44 B | |||
| Price To Sales | 2,083 X | |||
| Revenue | 190 K | |||
| Gross Profit | 52.81 K | |||
| EBITDA | (886.77 K) | |||
| Net Income | (57.28 K) | |||
| Cash And Equivalents | 5.76 K | |||
| Total Debt | 233.12 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.63) X | |||
| Cash Flow From Operations | 4.89 M | |||
| Earnings Per Share | (4.76) X | |||
| Beta | -0.0481 | |||
| Market Capitalization | 125.65 M | |||
| Total Asset | 3.31 M | |||
| Net Asset | 3.31 M |
About Enzolytics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enzolytics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enzolytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enzolytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Enzolytics Pink Sheet
Enzolytics financial ratios help investors to determine whether Enzolytics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enzolytics with respect to the benefits of owning Enzolytics security.